Mirati Therapeutics, Inc. (NASDAQ:MRTX) Q4 2022 Earnings Call Transcript

Operator: Good afternoon and welcome to the Mirati Therapeutics Fourth Quarter 2022 Earnings Call. My name is Cynthia and I'll be the operator for today's call.

Related Keywords

,Jamie Christensen ,Chuck Baum ,Alan Sandler ,James Christensen ,Goldman Sachs ,Bryan Asay ,Jonathan Miller ,Harshita Polishetty ,Ben Hickey ,Laurie Stelzer ,Tyler Van Buren ,Head Of Research ,Nasdaq ,Mirati Therapeutics Inc ,Exchange Commission ,European Union ,Health Photo ,National Cancer Institute On Unsplash ,European Medicines Agency ,Corporate Affairs At Mirati ,Mirati Therapeutics ,Call Transcript February ,Mirati Therapeutics Fourth Quarter ,Vice President ,Corporate Affairs ,David Meek ,Chief Executive Officer ,Chief Medical Officer ,Chief Scientific Officer ,Chief Commercial Officer ,Chief Financial ,Thanks Ben ,National Cancer Institute ,Fast Track ,Sitravatinib Phase ,Growth Consumer Stocks ,Profitable Mid Cap Stocks ,Van Buren ,Salveen Richter ,Gena Wang ,